Who owns TONIX PHARMACEUTICALS HLDG CO COM NEW?
- CUSIP Number: 890260854
Tip: Access positions for across all investors
Analyze quarterly positions in Tonix Pharmaceuticals Hldg with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tonix Pharmaceuticals Hldg stock
Who bought or sold TONIX PHARMACEUTICALS HLDG CO COM NEW this quarter?
There are no current stakeholders of Tonix Pharmaceuticals Hldg.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Tonix Pharmaceuticals Hldg?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Group | Mar 2024 | 531k | $99k |
| Armistice Capital | Mar 2024 | 489k | $91k |
| Northern Trust | Mar 2024 | 93k | $0 |
| BlackRock | Mar 2024 | 41k | $0 |
| Tower Research Capital | Mar 2024 | 34k | $6.4k |
| State Street Corporation | Mar 2024 | 31k | $5.8k |
| Rosalind Advisors | Jun 2024 | 28k | $20k |
| Morgan Stanley | Mar 2024 | 7.8k | $1.5k |
| Advisor Group Holdings | Mar 2024 | 32.00 | $6.000000 |
| Qube Research & Technologies | Mar 2024 | 4.00 | $1.000000 |
| Twin Lakes Capital Management | Jun 2024 | 1.00 | $1.000000 |